The efficacy and specificity of the anti-cancer drug tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), which targets malignant cells while sparing healthy ones, make it the best treatment for cancer [91]. Here, TNFSF10 is linked to cancer.